Acute muscular syndrome after bezafibrate.
D001629:Bezafibrate; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009212:Myoglobinuria / Q000139:chemically induced*
D000960:Hypolipidemic Agents; D002995:Clofibric Acid; D002994:Clofibrate; D001629:Bezafibrate